Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 11936 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 17669 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 19381 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 34751 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 36629 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 38537 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 38599 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 41257 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 41990 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 42388 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 46144 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 51387 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 57440 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 61730 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 65304 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 66161 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 67174 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 87203 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 90883 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 91455 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 98582 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 99956 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 101092 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 108720 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 113930 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 120171 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 123208 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 124000 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 126937 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 134721 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 147769 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 160054 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 161378 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 169000 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 174753 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 184952 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 210589 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 211917 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 218243 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 220702 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 221011 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 221987 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 238330 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 248830 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 262251 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 279270 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 291582 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 315297 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 349902 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 410332 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 490384 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 505838 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 552468 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 569138 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 574188 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 576903 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 617735 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 625957 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 757333 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 766695 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 880437 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 887160 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 888698 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 940130 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1104606 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1168398 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1214310 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1232515 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1323937 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1342793 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1349169 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1361597 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1413166 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1428477 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1456679 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1581236 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1706446 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1776782 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1827044 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 1849640 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 2114513 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 2194224 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 2544227 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 2555268 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 2569067 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 3113590 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 3383721 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 3464402 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | 3497673 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 1094 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 1591 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 2406 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 4074 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 4241 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 4321 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 4437 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 4835 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 5514 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 5516 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 7308 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 8001 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 8880 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 9249 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 9319 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 9998 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 10322 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 11127 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 11607 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 14383 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 14590 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 14973 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 15932 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 16408 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 17351 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 18944 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 19013 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 20586 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | 20825 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CAFFEINE (CAS# 58-08-2); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |